PharmaCielo Ltd. (PCLOF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.54 Million | 5.3 Million | 1.94 Million | 2.65 Million | 786.9 Thousand | - |
| Cost of Revenue | 2.91 Million | 4.48 Million | 6.25 Million | 9.45 Million | 2.44 Million | 653.62 Thousand |
| Gross Profit | -1.36 Million | 827.05 Thousand | -4.3 Million | -6.79 Million | -1.65 Million | -653.62 Thousand |
| Operating Expenses | -1.36 Million | 12.26 Million | 20.88 Million | 36.61 Million | 32.67 Million | 118.6 Thousand |
| Selling, General and Administrative Expenses | 8.22 Million | 11.48 Million | 19.01 Million | 32.33 Million | 30.52 Million | 118.6 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -9.59 Million | 873.13 Thousand | 136.63 Thousand | 949.03 Thousand | -218.72 Thousand | -25.79 Thousand |
| Cost and Expenses | 11.24 Million | 16.74 Million | 27.13 Million | 46.07 Million | 35.11 Million | 118.6 Thousand |
| Operating Income | -9.7 Million | -11.45 Million | -25.46 Million | -43.12 Million | -33.96 Million | -118.6 Thousand |
| Interest Expense | - | 1.53 Million | 561.29 Thousand | 272.73 Thousand | 173.84 Thousand | - |
| Income Tax Expense | - | 1.56 Million | 287.99 Thousand | 504.41 Thousand | -44.88 Thousand | -161.14 Thousand |
| Earnings before Tax | -16.29 Million | -14.51 Million | -26.62 Million | -43.75 Million | -34.66 Million | -144.39 Thousand |
| Net Income | -16.29 Million | -14.51 Million | -26.62 Million | -43.75 Million | -34.66 Million | -144.39 Thousand |
| Earnings Per Share Basic | -0.10 | -0.10 | -0.18 | -0.39 | -0.36 | -1.18 |
| Earnings Per Share Diluted | -0.10 | -0.10 | -0.18 | -0.39 | -0.36 | -1.18 |
| Weighted Average Shares Outstanding | 160.08 Million | 150.97 Million | 145.63 Million | 112.53 Million | 96.05 Million | 122.18 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 160.08 Million | 150.97 Million | 145.63 Million | 112.53 Million | 96.05 Million | 122.18 Thousand |
| Gross Margin | -0.89 | 0.16 | -2.22 | -2.56 | -2.11 | - |
| EBIT Margin | -7.91 | -1.86 | -12.45 | -15.66 | -41.53 | - |
| Profit Margin | -10.57 | -2.73 | -13.69 | -16.49 | -44.06 | - |
| EBITDA | -12.18 Million | -9.88 Million | -24.83 Million | -41.91 Million | -32.68 Million | -30.98 Million |
| Earnings Before Tax Margin | -6.29 | -2.16 | -13.09 | -16.25 | -43.16 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 783.68 Thousand | 240.26 Thousand | 1.54 Million | 244.02 Thousand | 351.68 Thousand | 159.53 Thousand |
| Cost of Revenue | 468.74 Thousand | 690.77 Thousand | 3.76 Million | 2.52 Million | 700.87 Thousand | 768.79 Thousand |
| Gross Profit | 314.93 Thousand | -450.5 Thousand | -2.22 Million | -2.28 Million | -349.18 Thousand | -609.25 Thousand |
| Operating Expenses | 1.9 Million | 1.24 Million | 8.33 Million | 1.3 Million | 1.98 Million | 2.42 Million |
| Selling, General and Administrative Expenses | 1.9 Million | 1.24 Million | - | 1.3 Million | 1.86 Million | 2.3 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 21.11 Thousand | 22.3 Thousand | 336.22 Thousand | -4898.00 | 180.69 Thousand | 71.26 Thousand |
| Cost and Expenses | 2.37 Million | 1.93 Million | 12.09 Million | 3.82 Million | 2.68 Million | 3.19 Million |
| Operating Income | -1.59 Million | -1.69 Million | -10.55 Million | -3.58 Million | -2.24 Million | -2.97 Million |
| Interest Expense | 887.91 Thousand | 680.68 Thousand | 2.69 Million | 906.34 Thousand | 614.48 Thousand | 620.31 Thousand |
| Income Tax Expense | -2.00 | -3.00 | 1.24 Million | 3.00 | 795.17 Thousand | 691.57 Thousand |
| Earnings before Tax | -2.57 Million | -2.42 Million | -16.29 Million | -6.39 Million | -2.76 Million | -3.58 Million |
| Net Income | -2.57 Million | -2.42 Million | -16.29 Million | -6.39 Million | -2.76 Million | -3.58 Million |
| Earnings Per Share Basic | -0.02 | -0.01 | - | -0.04 | -0.02 | -0.02 |
| Earnings Per Share Diluted | -0.02 | -0.01 | - | -0.04 | -0.02 | -0.02 |
| Weighted Average Shares Outstanding | 169.74 Million | 169.29 Million | 160.08 Million | 166.18 Million | 162.02 Million | 156.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.74 Million | 169.29 Million | 160.08 Million | 166.18 Million | 162.02 Million | 156.85 Million |
| Gross Margin | 0.40 | -1.88 | -1.44 | -9.35 | -0.99 | -3.82 |
| EBIT Margin | -1.59 | -5.48 | - | -10.03 | -5.35 | -16.39 |
| Profit Margin | -3.29 | -10.07 | -10.57 | -26.20 | -7.85 | -22.47 |
| EBITDA | -1.24 Million | -1.31 Million | - | -2.44 Million | -1.88 Million | -2.61 Million |
| Earnings Before Tax Margin | -2.03 | -7.07 | -6.85 | -14.68 | -6.37 | -18.65 |
8620
CBSTF
BJCHF
SBOK
GLOBALVECT
NGNE